Sign in
4

Changes in Ownership

INTERPACE BIOSCIENCES, INC. Filed Acc 0001493152-18-003187

Chief Commerical Officer acquired 28,000 shares (grant or award)

  • Chief Commerical Officer acquired 2,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Richard Gregory Chief Commerical Officer 2018-02-26 Option exercise +2,000 3,241 D: show line 1 in the form
Richard Gregory Chief Commerical Officer 2018-03-07 Grant or award +28,000 31,241 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Richard Gregory Chief Commerical Officer 2018-02-26 Option exercise · Restricted Stock Units −2,000 2,000 D: show line 3 in the form
Richard Gregory Chief Commerical Officer 2018-03-07 Grant or award · Stock Option (right to buy) +112,000 112,000 D: show line 4 in the form
Loading xslF345X03/form4.xml…